Organovo Holdings, Inc. ONVO
2.04 0.00 (+0.00%)
At closeApr 23, 2025, 4:00 PM EDT
1.94 Day range 2.16
52-week range unavailable
- YTD
- -63.04%
- 1 year
- -83.00%
News
zacks.com Will the ONVO L90's Fast Market Entry Boost NIO's Competitive Edge? NIO's ONVO sub-brand fast-tracks the L90 SUV launch, blending premium features with aggressive pricing in China's EV market.
globenewswire.com VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development.
globenewswire.com VivoSim to Carry Forward Organovo 3D Bioprinting SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
globenewswire.com Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
globenewswire.com Organovo Provides Business Update SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
globenewswire.com Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
benzinga.com Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected 
benzinga.com Nasdaq Gains Over 1%; Williams-Sonoma Shares Plunge After Q4 Results 
globenewswire.com Organovo Announces Reverse Stock Split SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel…
globenewswire.com Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward…
globenewswire.com Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises SAN DIEGO, March 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
benzinga.com Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings 
benzinga.com Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast 
globenewswire.com Organovo's FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
globenewswire.com Organovo Announces Appointment of Norman Staskey as Chief Financial Officer SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel…
globenewswire.com Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel…
globenewswire.com Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel…
invezz.com Nio stock poised for 42% gain on ONVO sales momentum Nio Inc (NYSE: NIO) opened more than 10% up on Thursday after a JPMorgan analyst issued a super bullish note in its favour. Nick Lai now sees upside in the EV stock to $8.0.
globenewswire.com Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis SAN DIEGO, July 16, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel…
globenewswire.com Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease Poster presented at DDW2024 demonstrating the potential of the Company's clinical-stage compound, FXR314, in combination with tofacitinib for treating IBD.
globenewswire.com Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) Organovo will be presenting data on the Company's lead clinical-stage drug, FXR314 during DDW2024, which is being held in Washington, D.C. May 18-21, 2024
globenewswire.com Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
benzinga.com Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic…
benzinga.com Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&P 500…
reuters.com Organovo's fatty liver disease drug meets main goal in mid-stage study Organovo Holdings said on Monday its experimental drug to treat a type of fatty liver disease met the main goal in a mid-stage study, sending its shares up nearly 27% in premarket trade.
globenewswire.com Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Conte- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 164 companies achieved new lows for the year.
benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 75 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 116 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 413 companies reached new 52-week lows.- benzinga.com 121 Stocks That Hit Their 52-Week Low New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
benzinga.com Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.- benzinga.com Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist…
- benzinga.com Coinbase, Moderna And 56 Biggest Movers From Yesterday Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert…
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 329 companies hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 951 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 126 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 615 stocks hit new 52-week lows.
- benzinga.com 61 Biggest Movers From Yesterday Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination…
- benzinga.com Cathie Wood's Ark Loads Up Further On Tesla And Cuts Apple Stake Cathie Wood-led Ark Investment Management on Tuesday snapped up $27.2 million worth of shares in Tesla Inc (NASDAQ: TSLA) after a two-week gap during which shares of the electric vehicle company have…
- benzinga.com Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ: AAPL) and continued to snap up shares of Coinbase Global Inc (NASDAQ: COIN).
benzinga.com Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday.- benzinga.com 48 Biggest Movers From Yesterday Gainers Welbilt, Inc. (NYSE: WBT) shares surged 44.5% to close at $22.58 on Wednesday after The Middleby Corporation announced plans to acquire the company.
- benzinga.com 80 Biggest Movers From Yesterday Gainers GameStop Corp. (NYSE: GME) shares surged 103.9% to close at $91.71 on Wednesday after the stock spiked on heavy volume. The stock in January saw a surge driven by high retail investor…
- benzinga.com 84 Biggest Movers From Yesterday Gainers AeroCentury Corp. (NYSE: ACY) shares climbed 414.9% to close at $13.85 on Monday after the company reported that the NYSE accepted its plan for continued listing.
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 58 Stocks Moving In Monday's Mid-Day Session Gainers AeroCentury Corp. (NYSE: ACY) shares jumped 227.2% to $8.80 after the company reported that the NYSE accepted its plan for continued listing.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday Wednesday morning saw 335 companies set new 52-week highs.